Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-3-26
pubmed:abstractText
We report molecular dynamics calculations of neuraminidase in complex with an inhibitor, 4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid (N-DANA), with subsequent free energy analysis of binding by using a combined molecular mechanics/continuum solvent model approach. A dynamical model of the complex containing an ionized Glu119 amino acid residue is found to be consistent with experimental data. Computational analysis indicates a major van der Waals component to the inhibitor-neuraminidase binding free energy. Based on the N-DANA/neuraminidase molecular dynamics trajectory, a perturbation methodology was used to predict the binding affinity of related neuraminidase inhibitors by using a force field/Poisson-Boltzmann potential. This approach, incorporating conformational search/local minimization schemes with distance-dependent dielectric or generalized Born solvent models, correctly identifies the most potent neuraminidase inhibitor. Mutation of the key ligand four-substituent to a hydrogen atom indicates no favorable binding free energy contribution of a hydroxyl group; conversely, cationic substituents form favorable electrostatic interactions with neuraminidase. Prospects for further development of the method as an analysis and rational design tool are discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-1056008, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-10602699, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-10764579, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-10813813, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-11020294, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-11063614, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-11274459, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-11457384, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-11509352, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-11906282, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-12471608, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-3054871, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-3186692, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-7512653, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-7549872, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-8358225, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-8558506, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-8592707, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-8906967, http://linkedlifedata.com/resource/pubmed/commentcorrection/15044728-9833666
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0961-8368
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
946-57
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Molecular dynamics and free energy analysis of neuraminidase-ligand interactions.
pubmed:affiliation
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester M13 9PL, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't